RankingsPricing
  1. US-listed companies
  2. PTC THERAPEUTICS, INC.
  3. Financials
  4. Marketable securities, current

PTC THERAPEUTICS, INC.PTCT

Market cap
$5.9B
P/E ratio
SummaryFinancials
Period EndMarketable securities, current (Million USD)YoY (%)
Dec 31, 2024360+27.32%
Dec 31, 2023283+116.04%
Dec 31, 2022131-77.58%
Dec 31, 2021584-34.78%
Dec 31, 2020895+124.53%
Dec 31, 2019399+586.09%
Dec 31, 201858-26.89%
Dec 31, 201779-54.16%
Dec 31, 2016173-38.29%
Dec 31, 2015281+5.80%
Dec 31, 2014265+108.96%
Dec 31, 2013127

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)